| Dick Bijl
| Physician-Epidemiologist, Private Practice, The Netherlands |
| Peter R. Breggin
| Private Practice of Psychiatry, USA |
| Elliot Brown
| Elliot Brown Consulting Ltd, UK |
| Rebecca Chandler
| Uppsala Monitoring Centre, Sweden |
| Andrzej Czarnecki
| Eli Lilly and Company, UK |
| Edzard Ernst
| University of Exeter, UK |
| Ulrich Hagemann
| International Society of Pharmacovigilance, Germany |
| Rokuro Hama
| Japan Institute of Pharmacovigilance, Japan |
| Ambrose Isah
| University of Benin, Nigeria |
| Donald Harvey Marks
| University of Pittsburgh, USA |
| Aleksandr Matveev
| Russian Medical Academy for Continuing Professional Education (RMANPO), Russia |
| Priscilla Patricia Nyambayo
| Munyaradzi Medicines Control, Zimbabwe |
| Emmanuel Okoro
| University of Ilorin, Nigeria |
| Abimbola Olowofela-Opadeyi
| Univeristy of Benin, Nigeria |
| Elena Rocca
| NMBU University, Norway |
| Mulugeta Russom
| Eritrean Pharmacovigilance Centre, Eritrea |
| Ruth Savage
| University of Otago, New Zealand |
| Anders Sundström
| Karolinska Institutet, Sweden |
| Michael Tatley
| Otago University, New Zealand |
| Eugene van Puijenbroek
| University Groningen, The Netherlands |
| Mauro Venegoni
| University of Verona, Italy |